Who owns Travere Therapeutics, Inc. (RTRX)? Elite investor 13F holders

4 tracked elite investors reported holding Travere Therapeutics, Inc as of 2026-09-30, including Renaissance Technologies LLC, D.E. Shaw, Polen Capital Management, Gotham Asset Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

4 tracked investors currently reported holding · Latest report period: 2026-09-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Renaissance Technologies LLCTRAVERE THERAPEUTICS INCSHARE2026-09-302026-11-12 00:00:0063477292.00 USD1078079.000000SharesreduceOriginal filing
D.E. ShawTRAVERE THERAPEUTICS INCSHARE2026-09-302026-11-16 00:00:0040818972.00 USD693257.000000SharesreduceOriginal filing
D.E. ShawTRAVERE THERAPEUTICS INCSHARE2026-09-302026-11-16 00:00:000.00 USD0.000000PrincipalexitedOriginal filing
Polen Capital ManagementTRAVERE THERAPEUTICS INCSHARE2026-09-302026-11-13 00:00:003119933.00 USD52988.000000SharesaddOriginal filing
Gotham Asset ManagementTRAVERE THERAPEUTICS INCSHARE2026-09-302026-11-16 00:00:002082821.00 USD35374.000000SharesaddOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown